omniture

AGBA Group Holding Limited (納斯達(dá)克編號(hào):AGBA) 宣布股份回購(gòu)計(jì)劃

香港2023年4月18日 /美通社/ -- 納斯達(dá)克上市公司AGBA Group Holding Limited(「AGBA」「匯邦」)是香港領(lǐng)先的一站式金融超市,董事會(huì)今天宣布批準(zhǔn)一項(xiàng)股份回購(gòu)計(jì)劃,授權(quán)以不超過(guò)10,000,000美元回購(gòu)最多1,000,000股AGBA普通股?;刭?gòu)反映AGBA致力回饋股東,為他們帶來(lái)價(jià)值,同時(shí)保持財(cái)務(wù)靈活性,以投資高增長(zhǎng)機(jī)會(huì)?;刭?gòu)計(jì)劃也顯示董事會(huì)對(duì)公司未來(lái)前景充滿信心。

AGBA集團(tuán)總裁吳榮輝表示:「AGBA注重創(chuàng)造和捍衛(wèi)股東利益。公司的龐大規(guī)模,加上雄厚的業(yè)務(wù)實(shí)力以及中國(guó)重新開(kāi)關(guān)所帶來(lái)的巨大機(jī)遇,讓我們能夠繼續(xù)進(jìn)行長(zhǎng)期投資,同時(shí)借由回購(gòu)計(jì)劃回購(gòu)公司股票?;刭?gòu)計(jì)劃明確反映我們認(rèn)為AGBA目前估值被嚴(yán)重低估,并表明我們對(duì)業(yè)務(wù)和未來(lái)的商機(jī)充滿信心。」

按適用的證券法例及監(jiān)管規(guī)定,AGBA或會(huì)不時(shí)在公開(kāi)市場(chǎng)回購(gòu)股份。公開(kāi)市場(chǎng)回購(gòu)將根據(jù)經(jīng)修訂的1934年證券交易法(「交易法」)第10b-18條進(jìn)行。

任何股份回購(gòu)的方式、時(shí)間和金額將由AGBA管理層根據(jù)其對(duì)普通股交易價(jià)格、市場(chǎng)和經(jīng)濟(jì)狀況、監(jiān)管要求和其他公司考慮因素等,作出評(píng)估及自行決定。

有關(guān)授權(quán)于2024年4月18日到期,并可能隨時(shí)暫?;蚪K止。公司亦沒(méi)有義務(wù)回購(gòu)任何數(shù)量的普通股。

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the outcome of any legal proceedings that may be instituted against us following the consummation of the business combination; expectations regarding our strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and our ability to invest in growth initiatives and pursue acquisition opportunities; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Hong Kong and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including its impacts across our business and operations. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

關(guān)于AGBA集團(tuán)

AGBA集團(tuán)(納斯達(dá)克:「AGBA」)成立于1993年,是一家以香港為基地的領(lǐng)先一站式金融超市,在粵港澳大灣區(qū)提供最廣泛的金融和醫(yī)療保健服務(wù),通過(guò)以技術(shù)為主導(dǎo)的生態(tài)系統(tǒng),讓客戶能夠選擇最適合他們需求的方案。AGBA擁有四大業(yè)務(wù):平臺(tái)業(yè)務(wù)、分銷業(yè)務(wù)、醫(yī)療保健業(yè)務(wù)和金融科技業(yè)務(wù),均領(lǐng)先于市場(chǎng),深受超過(guò)400,000名個(gè)人和企業(yè)客戶的信賴。

如欲了解AGBA更多資料,請(qǐng)瀏覽AGBA網(wǎng)站:www.agba.com

社交媒體:

agbagroup

LinkedIn | Twitter | Instagram | Facebook | YouTube

消息來(lái)源:AGBA Group Holding Ltd
相關(guān)股票:
NASDAQ:AGBA
China-PRNewsire-300-300.png
醫(yī)藥健聞
微信公眾號(hào)“醫(yī)藥健聞”發(fā)布全球制藥、醫(yī)療、大健康企業(yè)最新的經(jīng)營(yíng)動(dòng)態(tài)。掃描二維碼,立即訂閱!
collection